Oscar Health updated its full-year 2026 financial guidance during its Investor Day on September 16, 2026. The company improved its Medical Loss Ratio forecast to between 81.0% and 82.0%, a 50 basis point tightening from the previous range of 81.5% to 82.5%. Earnings from Operations guidance was raised by $100 million, now projected at $600 million to $800 million compared to the prior $500 million to $700 million estimate. Total Revenue and SG&A Expense Ratio targets remained reaffirmed at $18.7 billion–$19.0 billion and 15.6%–16.1%, respectively. Oscar Health operates in the health insurance industry, providing technology-driven healthcare coverage.
